Guardant Health, Inc. (GH) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Garden Health Q2 2025 Earnings Conference Call. My name is Jason and I'll be the moderator today. All lines will be muted during the presentation portion of the call and opportunity for questions and answers at the end. I would now like to pass the conference over to your host, Zarek Hurshid. Thank you. Earlier today, Garden Health released financial results for the quarter ended June 30th, 2025. Joining me today from GARDEN are Helmi El-Touki, co-CEO, Amir Ali Talitha, co-CEO, and Mike Bell, Chief Financial Officer. Before we begin, I'd like to remind you that during this call, management will make forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. This call will also include a discussion of non gap financial measures which are adjusted to exclude certain specified items. Additional information regarding material risks and uncertainties, as well as the non gap financial reconciliation to most directly comparable gap financial measures are available in the press release garden issued today, as well as in our 10 K and other filings with the SEC. This claims any intention or obligation to update or revise financial projections and forward-looking statements, whether because of new information, future events, or otherwise, except as required by law. The information in this conference call is accurate only as of the live broadcast. With that, I would like to turn the live call over to Helmi. Thanks, Eric. Good afternoon, and thank you for joining our second quarter 2025 earnings call. Starting on slide three, Q2 marked another exceptional quarter for Gardent. We continued to build momentum across oncology,...